Stoke Therapeutics Inc. (STOK)
NASDAQ: STOK
· Real-Time Price · USD
18.01
0.84 (4.89%)
At close: Aug 15, 2025, 3:06 PM
Stoke Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 13.82M | 158.57M | 22.61M | 4.89M | 4.83M | 4.22M | 2.8M | 3.31M | -2.48M | 5.15M | 3.27M | 2.9M | 3.23M | 3M | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 1.08M | 1.11M | 1.11M | 1.11M | 1.11M | 1.22M | 1.2M | 1.17M | 1.15M | 1.15M | 924K | 835K | 624K | 621K | 576K | 526K | 507K |
Gross Profit | 13.82M | 158.57M | 22.61M | 4.89M | 3.72M | 3.1M | 1.59M | 2.11M | -3.65M | 4M | 2.12M | 1.98M | 2.4M | 2.38M | -621K | -576K | -526K | -507K |
Operating Income | -27.3M | 111.24M | -13.65M | -30M | -29.34M | -28.37M | -29.59M | -27.23M | -33.26M | -20.44M | -27.18M | -27.15M | -25.24M | -24.8M | -24.53M | -22.68M | -22.03M | -16.83M |
Interest Income | n/a | 2.89M | 2.97M | 3.54M | 3.69M | 2.43M | 2.59M | 2.65M | 2.57M | 2.1M | 1.48M | 995K | 544K | n/a | 36K | n/a | 34K | 18K |
Pretax Income | -23.48M | 114.16M | -10.48M | -26.43M | -25.7M | -26.37M | -26.96M | -24.54M | -30.65M | -22.55M | -25.66M | -26.11M | -24.65M | -24.65M | -24.45M | -22.6M | -21.97M | -16.79M |
Net Income | -23.48M | 112.88M | -10.48M | -26.43M | -25.7M | -26.37M | -26.96M | -24.54M | -30.65M | -18.3M | -22.05M | -24.08M | -23.22M | -24.4M | -24.45M | -22.6M | -21.97M | -16.79M |
Selling & General & Admin | 15.26M | 14.65M | 12.84M | 12.69M | 12.47M | 9.67M | 10.02M | 10.27M | 10.23M | 10.21M | 9.38M | 9.94M | 10.11M | 9.49M | 8.72M | 8.32M | 7.93M | 6.91M |
Research & Development | 25.86M | 32.68M | 23.42M | 22.2M | 20.59M | 21.8M | 21.15M | 20.27M | 20.55M | 19.63M | 21.06M | 20.11M | 18.36M | 18.31M | 15.8M | 14.36M | 14.1M | 9.91M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 41K | 42K | 41K | 42K | 42K | 42K | 42K | 42K | 28K | 16K |
Operating Expenses | 41.12M | 47.33M | 36.27M | 34.9M | 33.06M | 31.48M | 31.17M | 30.54M | 30.78M | 29.84M | 30.44M | 30.05M | 28.47M | 27.8M | 24.53M | 22.68M | 22.03M | 16.83M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.57M | 2.1M | 1.48M | 995K | n/a | 104K | n/a | 44K | n/a | 12K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -562K | -550K | -591K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 41.12M | 47.33M | 36.27M | 34.9M | 34.17M | 32.59M | 32.39M | 30.54M | 30.78M | 29.84M | 30.44M | 30.05M | 28.47M | 27.8M | 24.53M | 22.68M | 22.03M | 16.83M |
Income Tax Expense | n/a | 1.28M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.25M | -3.61M | -2.03M | -1.43M | -250K | -78K | -44K | -34K | n/a |
Shares Outstanding (Basic) | 58.35M | 57.86M | 57.03M | 56.34M | 55.77M | 46.25M | 44.96M | 44.27M | 44.19M | 42.54M | 39.43M | 39.42M | 39.26M | 37.45M | 36.84M | 36.76M | 36.71M | 36.64M |
Shares Outstanding (Diluted) | 58.35M | 59.4M | 57.03M | 56.34M | 55.77M | 46.25M | 44.96M | 44.27M | 44.19M | 42.54M | 39.43M | 39.42M | 39.26M | 37.45M | 36.84M | 36.76M | 36.71M | 36.64M |
EPS (Basic) | -0.4 | 1.95 | -0.18 | -0.47 | -0.46 | -0.57 | -0.6 | -0.55 | -0.69 | -0.43 | -0.56 | -0.61 | -0.59 | -0.65 | -0.66 | -0.61 | -0.6 | -0.46 |
EPS (Diluted) | -0.4 | 1.90 | -0.18 | -0.47 | -0.46 | -0.57 | -0.6 | -0.55 | -0.69 | -0.43 | -0.56 | -0.61 | -0.59 | -0.65 | -0.66 | -0.61 | -0.6 | -0.46 |
EBITDA | -26.85M | 111.72M | -13.13M | -29.46M | -28.79M | -27.81M | -28.96M | -26.6M | -32.65M | -24.09M | -26.57M | -26.76M | -24.94M | -24.55M | -24.29M | -22.43M | -21.78M | -16.59M |
EBIT | -27.3M | 111.24M | -13.65M | -30M | -29.34M | -28.37M | -29.59M | -27.23M | -33.26M | -24.69M | -27.18M | -27.15M | -25.24M | -24.8M | -24.53M | -22.68M | -22.03M | -16.83M |
Depreciation & Amortization | 446K | 477K | 526K | 540K | 548K | 563K | 624K | 637K | 1.17M | 1.15M | 1.15M | 924K | 835K | 624K | 621K | 576K | 526K | 507K |